Arginine vasopressin deficiency (AVP-D) is one of the main entities of the polyuria-polydipsia syndrome. Its correct diagnosis and differentiation from the other two causes – AVP resistance and primary polydipsia – is crucial as this determines the further management of these patients.Over the last …
rowth in individuals with rapidly progressive ADPKD, but its long-term tolerability and effective implementation has yet to be studied, particularly in real-world clinical settings within…
This case report describes a unilateral basal ganglia hemorrhage passing through the anterior commissure within the canal of Gratiolet to the contralateral side.
Fibrates are a commonly utilized medication in the management of dyslipidaemia and cardiovascular risk. These agents have a well-documented association with reversible elevations in serum…
One of our strategic priorities is professional and business success and our approach to key learning objectives offers our members the opportunity to connect with…
“A Reflection on Advocacy: Lessons Learned From Capitol Hill” published on 07 May 2025 by American Society of Nephrology.
Colchicine reduces the risk of non-fatal ischaemic events in patients with ASCVD. Further studies are required to identify a population(s) who stands to benefit most…
The four NKF Executive Councils acknowledge the contributions of their members and those impacting the kidney community through annual awards given at the NKF Spring…
Over the last decade, covalent Bruton tyrosine kinase (BTK) inhibitors have become a standard option for treating patients with symptomatic Waldenström Macroglobulinemia (WM) in the…
The U.S. Food and Drug Administration said on Friday it had cleared Fujirebio Diagnostics’ blood test to diagnose Alzheimer’s disease, making the test the first…
